OBJECTIVE: Previous randomised trial data have demonstrated that male circumcision reduces Mycoplasma genitalium prevalence in men. We assessed whether male circumcision also reduces M genitalium infection in female partners of circumcised men. METHODS:HIV-negative men were enrolled and randomised to either male circumcision or control. Female partners of male trial participants from the intervention (n=437) and control (n=394) arms provided interview information and self-collected vaginal swabs that were tested for M genitalium by APTIMA transcription-mediated amplification-based assay. Prevalence risk ratios (PRR) and 95% CI of M genitalium prevalence in intervention versus control group were estimated using Poisson regression. Analysis was by intention-to-treat. An as-treated analysis was conducted to account for study-group crossovers. RESULTS:Male and female partner enrolment sociodemographic characteristics, sexual behaviours, and symptoms of sexually transmitted infections were similar between study arms. Female M genitalium prevalence at year 2 was 3.2% (14/437) in the intervention arm and 3.6% (14/394) in the control arm (PRR=0.90, 95% CI 0.43 to 1.89, p=0.78). In an as-treated analysis, the prevalence of M genitalium was 3.4% in female partners of circumcised men and 3.3% in female partners of uncircumcised men (PRR=1.01, 95% CI 0.48 to 2.12, p=0.97). CONCLUSIONS: Contrary to findings in men, male circumcision did not affect M genitalium infection in female partners.
RCT Entities:
OBJECTIVE: Previous randomised trial data have demonstrated that male circumcision reduces Mycoplasma genitalium prevalence in men. We assessed whether male circumcision also reduces M genitalium infection in female partners of circumcised men. METHODS: HIV-negative men were enrolled and randomised to either male circumcision or control. Female partners of male trial participants from the intervention (n=437) and control (n=394) arms provided interview information and self-collected vaginal swabs that were tested for M genitalium by APTIMA transcription-mediated amplification-based assay. Prevalence risk ratios (PRR) and 95% CI of M genitalium prevalence in intervention versus control group were estimated using Poisson regression. Analysis was by intention-to-treat. An as-treated analysis was conducted to account for study-group crossovers. RESULTS: Male and female partner enrolment sociodemographic characteristics, sexual behaviours, and symptoms of sexually transmitted infections were similar between study arms. Female M genitalium prevalence at year 2 was 3.2% (14/437) in the intervention arm and 3.6% (14/394) in the control arm (PRR=0.90, 95% CI 0.43 to 1.89, p=0.78). In an as-treated analysis, the prevalence of M genitalium was 3.4% in female partners of circumcised men and 3.3% in female partners of uncircumcised men (PRR=1.01, 95% CI 0.48 to 2.12, p=0.97). CONCLUSIONS: Contrary to findings in men, male circumcision did not affect M genitalium infection in female partners.
Authors: Supriya D Mehta; Charlotte Gaydos; Ian Maclean; Elijah Odoyo-June; Stephen Moses; Lawrence Agunda; Nicole Quinn; Robert C Bailey Journal: Sex Transm Dis Date: 2012-04 Impact factor: 2.830
Authors: Lisa E Manhart; King K Holmes; James P Hughes; Laura S Houston; Patricia A Totten Journal: Am J Public Health Date: 2007-04-26 Impact factor: 9.308
Authors: Aaron A R Tobian; David Serwadda; Thomas C Quinn; Godfrey Kigozi; Patti E Gravitt; Oliver Laeyendecker; Blake Charvat; Victor Ssempijja; Melissa Riedesel; Amy E Oliver; Rebecca G Nowak; Lawrence H Moulton; Michael Z Chen; Steven J Reynolds; Maria J Wawer; Ronald H Gray Journal: N Engl J Med Date: 2009-03-26 Impact factor: 91.245
Authors: Ronald H Gray; Godfrey Kigozi; David Serwadda; Frederick Makumbi; Fred Nalugoda; Stephen Watya; Laurence Moulton; Michael Z Chen; Nelson K Sewankambo; Noah Kiwanuka; Victor Sempijja; Tom Lutalo; Joseph Kagayii; Fred Wabwire-Mangen; Renée Ridzon; Melanie Bacon; Maria J Wawer Journal: Am J Obstet Gynecol Date: 2008-10-30 Impact factor: 8.661
Authors: Sue Napierala Mavedzenge; Barbara Van Der Pol; Helen A Weiss; Cynthia Kwok; Fidelis Mambo; Tsungai Chipato; Ariane Van der Straten; Robert Salata; Charles Morrison Journal: AIDS Date: 2012-03-13 Impact factor: 4.177
Authors: Cindy M Liu; Bruce A Hungate; Aaron A R Tobian; David Serwadda; Jacques Ravel; Richard Lester; Godfrey Kigozi; Maliha Aziz; Ronald M Galiwango; Fred Nalugoda; Tania L Contente-Cuomo; Maria J Wawer; Paul Keim; Ronald H Gray; Lance B Price Journal: mBio Date: 2013-04-16 Impact factor: 7.867
Authors: Jillian Pintye; Jared M Baeten; Lisa E Manhart; Connie Celum; Allan Ronald; Nelly Mugo; Andrew Mujugira; Craig Cohen; Edwin Were; Elizabeth Bukusi; James Kiarie; Renee Heffron Journal: Lancet Glob Health Date: 2014-10-22 Impact factor: 26.763
Authors: Johan H Melendez; Justin Hardick; Annet Onzia; Tong Yu; Peter Kyambadde; Rosalind Parkes-Ratanshi; Edith Nakku-Joloba; Agnes Kiragga; Yukari C Manabe; Matthew M Hamill Journal: Microbiol Spectr Date: 2022-04-12
Authors: Jonathan M Grund; Tyler S Bryant; Inimfon Jackson; Kelly Curran; Naomi Bock; Carlos Toledo; Joanna Taliano; Sheng Zhou; Jorge Martin Del Campo; Ling Yang; Apollo Kivumbi; Peizi Li; Sherri Pals; Stephanie M Davis Journal: Lancet Glob Health Date: 2017-11 Impact factor: 26.763